CNSX:VRT

Vertiv Competitors

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume2,475 shs
Average Volume73,073 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Vertiv (CNSX:VRT) Vs. THCX, GLH, ACG, HC, BIO, and BBM

Should you be buying VRT stock or one of its competitors? Companies in the industry of "drug manufacturers - specialty & generic" are considered alternatives and competitors to Vertiv, including (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Bio-Rad Laboratories (BIO), and Blueberries Medical (BBM).

(THCX.V) (CVE:THCX) and Vertiv (CNSX:VRT) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, profitability, analyst recommendations, valuation, risk and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations and price targets for (THCX.V) and Vertiv, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(THCX.V)0000N/A
Vertiv0000N/A

Valuation & Earnings

This table compares (THCX.V) and Vertiv's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(THCX.V)N/AN/AN/AN/AN/A
VertivN/AN/AN/AN/AN/A

Profitability

This table compares (THCX.V) and Vertiv's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(THCX.V)N/AN/AN/A
VertivN/AN/AN/A

31444 (CNSX:GLH) and Vertiv (CNSX:VRT) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends and earnings.

Analyst Ratings

This is a breakdown of current ratings for 31444 and Vertiv, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
314440000N/A
Vertiv0000N/A

Profitability

This table compares 31444 and Vertiv's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
31444N/AN/AN/A
VertivN/AN/AN/A

Valuation and Earnings

This table compares 31444 and Vertiv's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
31444N/AN/AN/AN/AN/A
VertivN/AN/AN/AN/AN/A

438280 (CNSX:ACG) and Vertiv (CNSX:VRT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, institutional ownership, risk, analyst recommendations and valuation.

Analyst Recommendations

This is a summary of recent ratings and target prices for 438280 and Vertiv, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
4382800000N/A
Vertiv0000N/A

Valuation & Earnings

This table compares 438280 and Vertiv's top-line revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
438280N/AN/AN/AN/AN/A
VertivN/AN/AN/AN/AN/A

Profitability

This table compares 438280 and Vertiv's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
438280N/AN/AN/A
VertivN/AN/AN/A

Vertiv (CNSX:VRT) and 815446 (CNSX:HC) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, profitability, risk, institutional ownership, analyst recommendations and dividends.

Valuation & Earnings

This table compares Vertiv and 815446's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VertivN/AN/AN/AN/AN/A
815446N/AN/AN/AN/AN/A

Analyst Ratings

This is a summary of current ratings for Vertiv and 815446, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vertiv0000N/A
8154460000N/A

Profitability

This table compares Vertiv and 815446's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VertivN/AN/AN/A
815446N/AN/AN/A

Vertiv (CNSX:VRT) and Bio-Rad Laboratories (CNSX:BIO) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations.

Profitability

This table compares Vertiv and Bio-Rad Laboratories' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VertivN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/A

Earnings & Valuation

This table compares Vertiv and Bio-Rad Laboratories' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VertivN/AN/AN/AN/AN/A
Bio-Rad LaboratoriesN/AN/AN/AN/AN/A

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Vertiv and Bio-Rad Laboratories, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vertiv0000N/A
Bio-Rad Laboratories0000N/A

Vertiv (CNSX:VRT) and Blueberries Medical (CNSX:BBM) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends.

Analyst Recommendations

This is a summary of current ratings and price targets for Vertiv and Blueberries Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Vertiv0000N/A
Blueberries Medical0000N/A

Profitability

This table compares Vertiv and Blueberries Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
VertivN/AN/AN/A
Blueberries MedicalN/AN/AN/A

Valuation and Earnings

This table compares Vertiv and Blueberries Medical's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VertivN/AN/AN/AN/AN/A
Blueberries MedicalN/AN/AN/AN/AN/A


Vertiv Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
THCX
(THCX.V)
0.6$5.30flatC$0.00N/A0.00High Trading Volume
GLH
31444
0.4N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ACG
438280
0.6N/AN/AC$0.00N/A0.00Gap Down
HC
815446
0.5N/AN/A$0.00N/A0.00Gap Down
BIO
Bio-Rad Laboratories
0.5N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
BBM
Blueberries Medical
0.6N/AN/A$0.00N/A0.00High Trading Volume
LOVE
Cannara Biotech
0.7N/AN/A$0.00N/A0.00High Trading Volume
CALI
China Auto Logistics
1.3N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
MJ
ETFMG Alternative Harvest ETF
0.5N/AN/A$0.00N/A0.00News Coverage
Gap Down
BOSS
Global X Founder-Run Companies ETF
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LHS
Liberty Health Sciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
LIB
Liberty Leaf
0.5N/AN/AC$0.00N/A0.00High Trading Volume
Gap Down
MMEN
Medmen Enterprises
0.6N/AN/A$0.00N/A0.00High Trading Volume
RQB
Ravenquest Biomed
0.6N/AN/A$0.00N/A0.00High Trading Volume
TGIF
SoFi Weekly Income ETF
0.6N/AN/A$0.00N/A0.00High Trading Volume
Valeant Pharmaceuticals International logo
VRX
Valeant Pharmaceuticals International
0.5N/AN/AC$0.00N/A0.00
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.